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The optimal virulence of a pathogen is determined by a trade-off between maximizing the rate of transmission and maximizing the
duration of infectivity. Treatment measures such as curative therapy and case isolation exert selective pressure by reducing the
duration of infectivity, reducing the value of duration-increasing strategies to the pathogen and favoring pathogen strategies that
maximize the rate of transmission. We extend the trade-off models of previous authors, and represents the reproduction number of
the pathogen as a function of the transmissibility, host contact rate, disease-induced mortality, recovery rate, and treatment rate,
each of which may be influenced by the virulence. We find that when virulence is subject to a transmissibility-mortality trade-off,
treatment can lead to an increase in optimal virulence, but that in other scenarios (such as the activity-recovery trade-off) treatment
decreases the optimal virulence. Paradoxically, when levels of treatment rise with pathogen virulence, increasing control efforts may
raise predicted levels of optimal virulence. Thus we show that conflict can arise between the epidemiological benefits of treatment
and the evolutionary risks of heightened virulence.
r 2004 Elsevier Ltd. All rights reserved.
Keywords: Evolution; Optimal virulence; Treatment; Mathematical model; Virulence management; Public health interventions; Disease control1. Introduction
While the development of drug resistance is perhaps
the best-known evolutionary response to treatment
programs, public health interventions may exert other
selective pressures on pathogens. There has been
mounting recognition of the need to understand the
balance between the immediate epidemiological benefits
and longer-term evolutionary risks of interventions
(Dieckmann et al., 2002; Gandon and Day, 2003; Elliot,
2003; Galvani, 2003). Recent work has revealed that
vaccines that reduce pathogen replication or toxicity
favor increased virulence, while vaccines that reduce thee front matter r 2004 Elsevier Ltd. All rights reserved.
i.2004.09.009
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ntrol Branch, 2151 Berkeley Way, Suite 608, Berkeley,
.susceptibility of hosts to infection select for lower levels
of virulence (Gandon et al., 2001, 2003). Here we
explore the effect of treatments that act by reducing the
infectious period, such as curative therapy or case
isolation measures, on the optimal virulence level of a
pathogen.
The evolutionary fitness of a pathogen is quantified by
its basic reproduction number (R0), which is the average
number of secondary cases generated by an initial
infection in a susceptible population (Anderson and
May, 1991; MacDonald, 1952). In the absence of within-
host competition among pathogen strains (Nowak and
May, 1994), the optimal virulence is determined by
maximizing R0 subject to trade-offs between epidemio-
logical parameters that are affected by pathogen
virulence (May and Anderson, 1983; Chapin, 1926).
However, the trade-off between disease-induced mortal-
ity (often taken as the definition of virulence) and
pathogen transmissibility (assumed to increase with
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Bull, 2003a). Recent work on virulence evolution has
explored the importance of host population structure
(Read and Keeling, 2003; Boots et al., 2004; Thrall and
Burdon, 2003) and more complex interactions between
epidemiological parameters (Andre et al., 2003; Ganu-
sov and Antia, 2003).
In this work, we define virulence as the extent of host
resource exploitation by the pathogen, which correlates
with harm to the host (and reduced fitness) (Sigmund et
al., 2002; Galvani, 2003; Poulin and Combes, 1999). We
review evidence that as virulence increases, the host may
be harmed in four ways: (1) increased mortality, (2)
slower recovery from infection, (3) reduced activity, i.e.
fewer contacts with other individuals, and (4) increased
probability of transmission given a contact. Further-
more, as increasing pathogen virulence worsens symp-
toms, rates of treatment or isolation of infectious hosts
may increase (Tuckett, 1976; Twaddle, 1979). Thus, we
consider evolution of pathogens with a wide range of
disease manifestations, including non-lethal infectious
diseases such as gonorrhea, and show under what
circumstances curative therapy or case isolation may
change the optimal virulence.2. The reproduction number Ru
Denoting the level of disease control or treatment
effort by u, the reproduction number Ru is the number
of secondary cases that would be generated by a single
case in a wholly susceptible population in the presence
of control at the level u. When there is no control and
u ¼ 0; Ru ¼ R0; increasing values of u denote increasing
treatment effort. We define the effective contact rate E
as the rate at which a susceptible produces new
infectives in a wholly susceptible population; for the
simple model of disease transmission (Anderson and
May, 1991; Bailey, 1975; Kermack and McKendrick,
1927) discussed in the Appendix, E ¼ bcy; where b is the
transmission probability per contact and cy is the
number of contacts per unit time; E is independent of
treatment effort u in this model. The mean duration of
infectivity D is given by (Anderson and May, 1991)
D ¼ 1
mþ dþ rþ fðuÞ ; (1)
where m is the background removal rate, d is the disease-
specific mortality rate, r is the recovery rate, and fðuÞ
the per-capita removal rate due to treatment or case
isolation. We assume that f always increases with the
effort u and that fð0Þ ¼ 0: The reproduction number
itself is then given simply by RuðvÞ ¼ EðvÞDðu; vÞ
Anderson and May (1991); this expresses the trade-off
between the effective contact rate and the duration oftransmission that determines the evolutionarily optimal
level of virulence.
In this paper, we will introduce plausible functional
forms for b; cy; d; r; and f in terms of pathogen
virulence v, and find explicit expressions for the optimal
virulence levels for a set of disease-dependent special
cases. This allows us to make predictions regarding the
effect of treatment on optimal virulence levels, including
cases where treatment rates are higher for more virulent
pathogens. We will characterize how changes in treat-
ment effort u affect the values v for which RuðvÞ is
maximized, and show that curative treatment influences
optimal virulence by reducing the benefits the pathogen
can obtain from strategies that increase the duration of
infectiousness.3. Pathogen strategies
All else being equal, a pathogen benefits from a large
transmissibility b and host activity level cy; and a small
recovery rate r and death rate d; thus maximizing both
the effective contact rate and duration of infectivity.
However, recent theory has emphasized that these
parameters may not, in general, vary independently.
For instance, increasing transmissibility may be possible
only through enhanced virulence, which in turn may
lead to an increased mortality or to reduced contact rate
(see discussion in Lipsitch and Moxon, 1997). We now
review evidence for the dependence of disease-induced
death rates, host activity levels, transmissibility, and
recovery rates on the level of virulence.
The link between pathogen virulence and disease-
induced mortality is clear. Indeed, in many studies
virulence is defined as the increase in mortality rate due
to disease (Day, 2002). In this study, we treat cases
where disease mortality rates d are linearly proportional
to virulence (the standard assumption), or where the
pathogen produces no disease-induced mortality, but
harms the host in other ways.
As virulence is increased, the normal activities of the
host may become increasingly impeded, leading to a
potential reduction of the contact rate cy (e.g. (Ewald,
1994; Upchurch et al., 1989; Lloyd-Smith et al., 2004)).
Symptoms themselves may lead to behavioral changes
(such as increased sleep, reduced sexual activity, and
decreased mixing in the community) (Dunn and
Swiergiel, 1998) arising from pathogen resource exploi-
tation or the cost of immune response (Levin and Antia,
2001). We consider the case where host contact rate is a
concave-up decreasing function of pathogen virulence.
Greater pathogen loads within hosts may yield higher
transmission probability per contact (‘‘transmissibil-
ity’’), b; due to higher pathogen concentrations in
bodily fluids or to more severe symptoms (Ewald,
1994; Levin, 1996). For example, coughing expels
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tions such as influenza (Kilbourne, 1987) and tubercu-
losis (Hopewell and Bloom, 1994). Higher densities of
pathogen should, all else being equal, result in a more
virulent or harmful infection. Thus, a positive relation-
ship between the transmissibility and virulence (Bre-
mermann and Pickering, 1983; May and Anderson,
1983; Ewald, 1994; Lipsitch and Moxon, 1997) may
occur in many host-pathogen systems, including Schis-
tosoma mansoni (Davies et al., 2001), trypanosomes
(Diffley et al., 1987), influenza (Van dergoot et al.,
2003), myxoma virus in rabbits (Fenner and Ratcliffe,
1965; Anderson and May, 1991), Plasmodium species
(Mackinnon and Read, 1999), canine parvovirus (Meu-
nier et al., 1985) and HIV (Khouri et al., 1995; Jacquez
et al., 1994; Riddler and Mellors, 1997; Katzenstein and
Holodniy, 1995/1996; Katzenstein et al., 1996; Coombs
et al., 1996; Craib et al., 1997; Fiore et al., 1997; Quinn
et al., 2000). We treat the case where transmissibility is a
concave-down increasing function of virulence, where
necessarily 0pbðvÞp1; with an independent parameter
b1 determining whether a completely avirulent strain
(v ¼ 0) is still transmissible (as are many commensal
microorganisms (Hooper and Gordon, 2001)); see Eq.
(9) below for details.
Pathogens are under selection to evade immunity and
hence prolong infection. For example, trypanosomes
and malarial parasites undergo antigenic variation
within single infections. Heightened virulence has been
found to prolong the period of infectiousness in lizard
malaria Plasmodium mexicanum (Eisen and Schall,
2000), myxoma virus in rabbits (Fenner and Ratcliffe,
1965; Anderson and May, 1991), canine parvovirus
(Meunier et al., 1985), Bordetella avium (Temple et al.,
1998), hepatitis B virus (Fong et al., 1994) and influenza
(Van dergoot et al., 2003). We explore the case in which
the recovery rate r is a decreasing (or at least non-
increasing) function of the virulence parameter v. (Note
that a recovery rate that increases with the virulence
could be subsumed into the increasing mortality rate d
without loss of generality.)4. Disease control strategy
We denote the level of disease control effort by u, such
that the treatment rate f increases as u increases (i.e.
df
du
40), and fðu ¼ 0Þ ¼ 0: The effect of treatment is to
remove individuals from the infective class at rate f;
examples are tuberculosis (Comstock and Cauthen,
1993) and gonorrhea (DeMaio and Zenilman, 1998)
for curative therapy, or severe acute respiratory
syndrome (SARS) (Lloyd-Smith et al., 2003) and
smallpox (e.g. Porco et al., 2004) for case isolation.
The treatment rate f may also be related to the
virulence, since treatment should be sought more oftenas symptoms become more severe (Tuckett, 1976;
Twaddle, 1979). Severe symptoms may also increase
control efforts for contact tracing, resulting in prophy-
lactic treatment or quarantine, as occurred during the
recent SARS outbreak (e.g. Lloyd-Smith et al. (2003)).
We therefore consider the general case where f depends
on u and v, as well as the special case of virulence-
independent treatment.5. The optimal virulence under treatment
We assume vX0; so if Ru decreases monotonically
with v, the optimal virulence is v ¼ 0: Otherwise, a local
maximum of Ru occurs at v
 if
@Ru
@v
ðu; vðuÞÞ ¼ 0 (2)
and
@2Ru
@v2
ðvÞo0:
The virulence level at which Ru is maximized may also
be found by substituting R ¼ ED into Eq. (2) and
finding the value v which solves
1
E
@E
@v
¼  1
D
@D
@v
: (3)
This condition corresponds to that value of the virulence
for which gains in effective contact rate are exactly
balanced by losses in duration of infectivity, or vice
versa. When the form of E is unimodal, let vt denote
the value of v at which E is maximized; similarly, when
D is unimodal in v for a particular u, we may denote by
vd that value of v such that D is maximized. In the
case of virulence-independent treatment, vd is indepen-
dent of u.
We are interested in the sign of dv

du
; i.e. does increasing
treatment effort lead to higher or lower levels of optimal
virulence? Differentiating Eq. (2) with respect to u and
rearranging leads to an expression for the dependence of
the optimal virulence v on the control variable u:
dv
du
¼ 
@
@u
@Ru
@v
@2Ru
@v2
(4)
provided @
2Ru
@v2
a0: If vðuÞ corresponds to a local
maximum of Ru and
@2Ru
@v2
a0; then @
2Ru
@v2
o0: In this
case, from Eq. (4) we see that dv

du
40 if and only if
@
@u
@Ru
@v 40: Thus, if increases in the control variable u
increase the marginal fitness with respect to the
virulence, then the treatment program will increase the
optimal virulence of the pathogen and thus provide a
selective pressure for the pathogen virulence to increase.
To determine the sign of @@u
@Ru
@v at the optimal
virulence, we first observe that Eq. (1) implies that @D@u ¼
D2 @f@u; and since E has no explicit dependence on u,
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@u ¼ 0: Since, by definition, Ru ¼ ED;
@
@u
@Ru
@v
¼ E @
@v
@D
@u
þ @D
@u
1
E
@E
@v
 
:
Substituting @D@u ¼ D2 @f@u and rearranging leads to
@
@u
@Ru
@v
¼ ED2 2  1
D
@D
@v
@f
@u
 
 @
2f
@u @v
 @f
@u
1
E
@E
@v
 
:
(5)
Eqs. (3) and (5) together imply that at v;
@
@u
@Ru
@v
¼ ED2 1
E
@E
@v
@f
@u
 @
@v
@f
@u
 
: (6)
Hence for E40 and D40; and both D and E unimodal
in v, Eq. (6) implies that @@u
@Ru
@v 40 if and only if
1
E
@E
@v
ðvðuÞÞ4 1
@f
@u ðvðuÞ; uÞ
@
@v
@f
@u
ðu; vðuÞÞ: (7)
Therefore, from condition (4), dv

du
40 if and only if Eq.
(7) holds. That is, the optimal virulence increases with
greater treatment effort if and only if the relative
increase in E per unit increase in v outweighs the relative
increase in the marginal treatment rate @f@u:vd vt
-0.2
0.0
R
el
at
iv
e
0 1 2 3 4 5
Virulence
e
0.03
0.04
0.05
(A)6. Virulence-independent treatment
In the case of virulence-independent treatment, @@v
@f
@u ¼
0: Since by assumption @f@u40 (and EðvÞ40), it follows
from (7) that dv

du
40 if and only if
@E
@v
ðvÞ40: (8)
In the example shown in Fig. 1, unimodal curves for E
and D are plotted from the functional forms for
parameters proposed below. The optimal virulence v
occurs at the unique intersection of the e  1
E
@E
@v and d 
1
D
@D
@v curves (Eq. (3)); in Fig. 1A,
@E
@v ðvÞ40 and vt4vd ;
whereas in Fig. 1B, @E@v ðvÞo0 and vtovd : Two curves for
d are shown: the dashed curve d2 corresponds to aFig. 1. Virulence dependence of the relative rate of change of
the effective contact rate (e  1
E
@E
@v) and the duration (d  1D @D@v ;
where the solid line d1 and dashed line d2 correspond to lower and
higher treatment rates, respectively.) The curves correspond to
the case EðvÞ ¼ E1ðvÞ ¼ ðb0b1Þvvþv0 þ b1
 
c0v1
vþv1 and Dðv; uÞ ¼ D1ðv; uÞ ¼
1
mþfðuÞþd0vþ
r0v3
vþv2
: (A) Increasing treatment increases the optimal viru-
lence, since the dashed line d2 intersects the e-curve at larger virulence.
(Parameter values: d0 ¼ 0:2 per unit time, r0 ¼ 0:1 per unit time, b0 ¼
0:3; b1 ¼ 0;v0 ¼ 5; c0 ¼ 20 per unit time, v1 ¼ 2; v2 ¼ 0; v3 ¼ 1; for the
low treatment line, mþ f ¼ 0:05 per unit time, and for the high
treatment dashed line, mþ f ¼ 0:3 per unit time.) (B) Increasing
treatment decreases the optimal virulence, since the dashed line d2
intersects the e-curve for smaller values of v. (Parameter values: as in A
except d0 ¼ 0:005 per unit time.)higher treatment rate f than the solid curve d1:
Increasing treatment flattens the d-curve, and shifts the
optimal virulence away from the duration maximizing
value vd and toward the transmission-rate maximizing
value vt: Hence, the optimal virulence increases when
vt4vd ; and decreases when vtovd : The figure illustrates
the following proposition (proven in the appendix).
Proposition. If treatment rates are independent of
pathogen virulence, and D and E are differentiableincreasing
treatment
decreasing optimal virulence
v*
v*
d2
vdvt
d1
-0.05
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maximum of E occurs, and vd being the point at which
the maximum of D occurs (being independent of u),
then dv

du has the same sign as vt  vd :
At the value vt that maximizes transmission, increas-
ing the virulence decreases the effective contact rate (E),
but produces a larger proportional increase in the
duration of infectivity (D), so the overall product Ru ¼
ED is larger (Fig. 2). The effect of treatment is to reduce
the potential proportional increase in the duration that
is possible by changes in virulence, and by reducing the
value of ‘‘trading off’’ transmission for duration, to shift
the overall optimum v (upwards or downwards) toward
the transmission-rate maximizing value vt: Hence, as the
treatment rate f increases, recovery and mortality
become less important as determinants of duration.
Based on the empirical evidence outlined above,
plausible functional forms for the four epidemiological
parameters are as follows:
bðvÞ ¼ ðb0  b1Þv
vþ v0
þ b1; (9)increasing Ru
pathogen
vt
vd
v*
0
1
2
3
4
D
ur
at
io
n
0 0.2 0.4 0.6 0.8 1.0 1.2
Effective Contact Rate
strategies
Fig. 2. Relationship between vt; vd ; and v as indicated on a
parametric plot of the effective contact rate EðvÞ and the duration of
infectivity DðvÞ as a function of the virulence; the dashed curves are
contours of Ru: At the points labeled vt and vd the effective contact rate
and duration of infectivity are maximized, respectively. At the point
labeled v; the reproduction number is maximized. The solid curve
corresponds to the case EðvÞ ¼ E1ðvÞ and DðvÞ ¼ D1ðvÞ as given in Fig.
1, with parameters as in Fig. 1A.
Treatment Rate
Fig. 3. Changes in optimal virulence due to increasing treatment for
the case EðvÞ ¼ E1ðvÞ and DðvÞ ¼ D1ðvÞ (as given in Fig. 1) are
illustrated for a range of values of b1 (indicated above each curve).
Other parameter values are b0 ¼ 0:3; v0 ¼ 5; c0 ¼ 20 per unit time,
v1 ¼ 2; d0 ¼ 0:025 per unit time, r0 ¼ 0:25 per unit time, m ¼ 0:01 per
unit time, v2 ¼ 0:3; and v3 ¼ 0:35:cyðvÞ ¼
c0v1
vþ v1
; (10)
dðvÞ ¼ d0v (11)
and
rðvÞ ¼ r0v3
vþ v2
: (12)
For the most general case, the change in optimal
virulence as the treatment level increases is illustrated
numerically for a range of values of b1 (the transmission
probability when v ¼ 0) in Fig. 3. When b1 ¼ 0; the
optimal virulence increases as the treatment level
increases; by the time b1 ¼ 0:1; the optimal virulence
decreases as the treatment level increases.7. Special cases
There are six simple special cases in which two of the
four parameters b; cy; r; and d vary with the virulence
(Table 1). In the transmissibility-recovery case, the
transmissibility b and the recovery rate r are functions
of virulence and cy and d are constant; then the optimal
ARTICLE IN PRESS
Table 1
Special cases
Scenario bðvÞ cyðvÞ dðvÞ rðvÞ v
TR ðb0b1Þv
vþv0 þ b1 c0 (constant) 0
r0v3
vþv2 1
CM b0 (constant)
c0v1
vþv1 d0v 0 0
CT ðb0b1Þv
vþv0 þ b1
c0v1
vþv1 0 0 vt ¼ b1v0þ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
v0ðb0b1Þðb0v1b1v0Þ
p
b0
RM b0 (constant) c0 (constant) d0v
r0v3
vþv2 vd ¼ max 0;v2 þ
ffiffiffiffiffiffiffi
r0v3
d0
q 
CR b0 (constant)
c0v1
vþv1 0
r0v3
vþv2 Eq. (14)
TM ðb0b1Þv
vþv0 þ b1 c0 (constant) d0v 0 Eq. (15)
T.C. Porco et al. / Journal of Theoretical Biology 233 (2005) 91–10296virulence v ! 1: In the contact-mortality case, the
contact rate cy decreases with virulence and the
mortality rate d increases with the virulence, but b and
r remain constant; here, v ¼ 0: More interesting are the
four remaining cases.
Contact–Transmissibility Trade-off (CT): In this case,
the transmissibility b increases and the contact rate cy
decreases as the virulence increases, while the duration
of infectivity is independent of virulence (Table 1). The
optimal virulence maximizes the effective contact rate:
v ¼ vt ¼ b1v0þ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
v0ðb0b1Þðb0v1b1v0Þ
p
b0
and does not depend
on the treatment rate. Such a scenario may occur when
the duration of infectivity is determined by the time
required for the host to mount a sufficient immune
response.
Recovery–Mortality Trade-off (RM): In this scenario,
the mortality rate increases and the recovery rate
decreases as pathogen virulence increases (Bremermann
and Pickering, 1983; Kaitala et al., 1997; May and
Anderson, 1983; van Baalen, 1998), but neither the
transmissibility nor the contact rate depend on
the virulence (Table 1). Here, the optimal virulence
is the duration maximizing value v ¼ vd ¼
max 0;v2 þ
ffiffiffiffiffiffiffi
r0v3
d0
q 
and does not depend on the
treatment rate; increasing treatment results in shorter
durations of infectivity, but the optimum virulence is
unaffected.
Contact–Recovery Trade-off (CR): In this case, as the
pathogen becomes more virulent, the contact rate and
the recovery rate decrease. We assume that the
transmissibility and mortality rates are not dependent
on the virulence (d0 ¼ 0; without loss of generality) as
shown in Table 1; the maximum effective contact rate is
attained at vt ¼ 0; the maximum duration of infectivity
is attained as vd !1: In this case, Ru decreases in v for
vX0; provided
f4
r0v3ðv1  v2Þ
v22
 m: (13)
Since f is positive, Eq. (13) is always satisfied whenever
v1pv2; whenever Eq. (13) is satisfied, v ¼ 0: When Eq.(13) is not satisfied, the optimal virulence is given by
v ¼ max 0;v2 þ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
r0v3ðv1  v2Þ
mþ f
s !
: (14)
The value of v never increases with treatment intensity
f: When r0v3ðv1v2Þ
v2
2
 mo0; the optimal virulence is
always zero, no matter what the treatment level is. This
is because (13) is satisfied for all f and Ru must be
monotone decreasing. If v2 ¼ 0; so that r ¼ r0v3v ; then
v ¼
ffiffiffiffiffiffiffiffiffiffi
r0v1v3
mþf
q
; which is always positive and strictly
decreases as f increases; increasing treatment results in
a decreasing optimal virulence.
Transmission–Mortality Trade-off (TM): We extend
the standard assumption of a positive relationship
between increased transmissibility and increased mor-
tality (Bremermann and Pickering, 1983; Bremermann
and Thieme, 1989; Day, 2002; Frank, 1996; Lipsitch and
Moxon, 1997; Lipsitch and Nowak, 1995; Stearns, 2000;
van Baalen, 2002; Frank, 2002) to include effects of
treatment (see Table 1). As the virulence increases, the
transmission rate increases, and the maximum effective
contact rate is attained as vt !1: If the recovery rate is
also unaffected and the mortality rate increases with the
virulence according to the assumptions given in Table 1,
then as the virulence increases, the duration of
infectivity decreases (Bremermann and Pickering, 1983;
Lenski and May, 1994); the maximum duration of
infectivity is attained at vd ¼ 0: The optimal virulence is
given by
v ¼ max
0;
v0b1d0 þ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
d0v0ðb0  b1Þðb0ðmþ fÞ  v0b1d0Þ
p
d0b0
 !
ð15Þ
whenever the term under the radical is nonnegative, and
zero otherwise. Here, v never decreases as f increases
(or equivalently, since f increases as the control effort u
increases, dv

du
X0). In this case, the transmission-rate
maximizing value vt !1; and the duration maximizing
value vd ¼ 0: Since the duration maximizing value vd is
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Fig. 4. Changes in optimal virulence due to increasing treatment for
the transmissibility-mortality case (the case TM in Table 1). The solid
curved line in each case shows bðvÞ; the straight lines show
combinations of b and v corresponding to constant values of Ru (see
text for details). (A) For the case of virulence-independent treatment,
the high-treatment dashed line intersects the bðvÞ curve for higher
values of the virulence than the low-treatment solid line. (Parameter
values: c0 ¼ 20 per unit time, d0 ¼ 0:1; b0 ¼ 0:3; b1 ¼ 0; v0 ¼ 5; r ¼ 0;
for the solid line, mþ f ¼ 0:1 per unit time and Ru ¼ 5:7; for the
dashed line, mþ f ¼ 0:3 per unit time and Ru=3.9.) (B) Virulence-
dependent treatment illustrated for f ¼ k0uv; the dashed line
corresponds to the largest possible value of Ru for the given b-v
relationship. The point of tangency occurs at a lower value of
virulence: increasing treatment rates for more virulent organisms
outweighs the benefit of increased transmission rates, and so increasing
treatment effort reduces the optimal virulence. (Parameter values:
same as for part A, except m ¼ 0:1 per unit time, k0 ¼ 1 and u ¼ 0 for
the solid line and u ¼ 0:1 for the dashed line.)
T.C. Porco et al. / Journal of Theoretical Biology 233 (2005) 91–102 97below the transmission-rate maximizing value vt; in-
creasing levels of treatment lead to a nondecreasing
optimal virulence. In particular, whenever f4v0b1d0b0b1  m;
the optimal virulence is greater than zero, and increases
as f increases. Observe that whenever v0b1d0b0b1  m40; the
optimal value of v is zero for low treatment values, and
remains so until f has become sufficiently large.
The increase in optimal virulence with treatment for
the case TM is illustrated in a standard graphical
approach to determine the evolutionarily stable level of
virulence (Dieckmann et al., 2002) (Fig. 4A). For
simplicity, we assume b1 ¼ 0 for this figure, so thatv ¼
ffiffiffiffiffiffiffiffiffiffiffiffi
v0ðmþfÞ
d0
q
: The curve shows values for which the
relationship bðvÞ ¼ b0v
vþv0 is satisfied. All values of v and b
for which the reproduction number Ru takes on any
particular value lie on a straight line; steeper slopes
correspond to larger Ru; and the v-intercept is deter-
mined by the treatment rate f (vintÞ ¼ mþrþfd0 : For
concave-down bðvÞ curves, the optimal virulence v is the
virulence level corresponding to the point of tangency—
where the slope is steepest. As f increases under
virulence-independent treatment, the intercept moves
left, but the point of tangency moves right (the optimal
virulence increases).
In general, continuity of Ru does not guarantee
continuity of the value of v which maximizes is, as a
function of u (Bank et al., 1983). A simple numerical
example is provided by
bðvÞ ¼ b1 þHðv v^Þ
ðb0  b1Þðv v^Þ
v v^þ v0
;
c ¼ c0v1=ðvþ v1Þ; rðvÞ ¼ r0; dðvÞ ¼ d0v; f ¼ ku; and
HðxÞ denotes the unit step function. Letting c0 ¼ 20;
v1 ¼ 2; b0 ¼ 0:4; b1 ¼ 0:06; v0 ¼ 2; v^ ¼ 1; r0 ¼ 0:1; d0 ¼
0:2; and k ¼ 1; we find that the product Ru ¼ ED is
bimodal, and the value v that optimizes Ru jumps from
0 to approximately 2.09 at u  0:8: Near this value,
small additional increases in the control effort cause
large changes in the optimal virulence.8. Virulence-dependent treatment
While selective pressure due to increased treatment of
more virulent strains of a pathogen may be expected to
reduce the optimal virulence (Galvani, 2003), Eq. (7)
shows that it is possible for treatment to increase the
optimal virulence even when more virulent strains are
treated more rapidly than less virulent strains. Large
positive values for @@v
@f
@u reverse the inequality in Eq. (7)
so that increasing treatment reduces the optimal
virulence. Small positive values of @@v
@f
@u would result in
slight increases or decreases in the optimal virulence.
8.1. Example
The bilinear form fðu; vÞ ¼ k0uv provides a simple
functional form in which the treatment rate f increases
with increasing control effort u and with the virulence v;
substituting in Eq. (7) reveals that the qualitative effect
of treatment on optimal virulence levels is determined by
how the effective contact rate EðvÞ and marginal
treatment rate @f@u vary with pathogen virulence. We first
assume that virulence affects both contact rates cy and
transmissibility b according to Eqs. (9) and (10). Since
@f
@u ¼ k0v; the right-hand side of Eq. (7) is 1v; it can then be
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E
@E
@v  1vo0 for any positive v ¼ v; Eq. (7) is
not satisfied, and increasing treatment necessarily results
in a decrease in the optimal virulence when fðuÞ ¼ k0uv:
The same result holds when only cy or only b depends on
virulence.
We next reconsider in detail the special case TM
(using the parameters in Table 1), under the assumption
that the treatment rate increases with pathogen virulence
according to f ¼ k0uv: If
b0b1v0k
0uþ b0b1d0 þ b0b1m b20mo0; (16)
then the optimal virulence is given by
v ¼  v0b1
b0
þ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
v0ðb0  b1Þ
b20
mb0
k0uþ d0
 v0b1
 s
;
which decreases as u increases. As u increases, the left-
hand side of the inequality (16) increases, until finally it
becomes greater than zero. When this occurs and
inequality (16) is not satisfied, Ru monotonically
decreases in v, and the optimal virulence is given by v ¼
0: Further increases in u continue to increase the left hand
side of the inequality (16), but cannot further decrease v
below 0. If b1 ¼ 0; the optimal virulence reduces to
v ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
mv0
k0uþ d0
r
;
which decreases monotonically for all u and approaches 0
as u !1: For a TM trade-off and f ¼ k0uv; therefore,
increasing treatment effort u always causes decreases in
the optimal virulence level v; this contrasts with the
above results for a TM trade-off under virulence-
independent treatment, for which dv

du
40 (Eq. (15)).
This case (TM trade-off with f ¼ k0uv and b1 ¼ 0) is
illustrated in Fig. 4B. As in Fig. 4A, the curve shows the
relationship bðvÞ and straight lines show combinations
of b and v that yield fixed values of Ru: Steeper lines
correspond to higher values of Ru; and the optimal
virulence (for a given v-intercept) is determined by the
point of tangency. For f ¼ k0uv; the v-intercept of the
constant-Ru lines is vint ¼  mþrk0uþd0: Increasing treatment
effort u shifts the v-intercept to the right and causes the
optimal virulence to decrease, as can be seen by
comparing the dashed line (virulence-dependent treatment
following f ¼ k0uv) to the solid line (no treatment).
Other simple formulations of virulence-dependent
treatment rates can yield opposite results, though,
contrary to the intuitive expectation that targeting more
virulent strains will exert selective pressure to decrease
virulence. We illustrate with a simple example: fðu; vÞ ¼
uðk þ k0vÞ: When fðu; vÞ ¼ uðk þ k0vÞ; the optimal viru-
lence is given by
v ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðmþ kuÞv0
d0 þ k0u
s
: (17)First note that when k0 ¼ 0 treatment is virulence-
independent, and increasing the treatment rate increases
the optimal virulence as in Fig. 4A. When k040; the
outcome depends on the relative magnitude of the
virulence-dependent and -independent components of f
(i.e. k0 versus k). When k04kd0m ; increasing the treatment
rate will decrease the optimal virulence. When k0okd0m ;
however, the treatment rate does not increase fast
enough as virulence increases, and so increasing treat-
ment leads to higher optimal virulence for the pathogen
(i.e. the same qualitative behavior as the virulence-
independent treatment case). Therefore, faster treatment
of more virulent strains does not always exert sufficient
selective pressure for increasing treatment effort to
decrease the optimal virulence; the benefit to the
pathogen of increased transmissibility can outweigh
the cost of the higher treatment rate.9. Discussion
The optimal virulence of a pathogen may either
increase or decrease in response to treatments that
reduce the duration of infectivity, such as curative
therapy and case isolation. Under the prevalent theory
of virulence evolution, pathogen virulence evolves
according to a trade-off between maximizing the
number of new cases generated per unit time and
maximizing the duration of infectivity. Treatment
interventions reduce the value of duration-increasing
strategies. Consequently, treatment shifts the optimal
virulence toward values which produce larger numbers
of new cases per unit time. This may result in increases
or decreases of optimal virulence levels, depending on
whether the virulence level that maximizes duration
(independent of transmission) is below or above the
virulence level that maximizes transmission (indepen-
dent of duration). We applied this result to several
special cases, extending trade-off models of previous
authors, for the situation where treatment rates are
independent of pathogen virulence. We found that when
virulence is subject to a transmissibility-mortality trade-
off, increasing treatment would lead to an increase in
optimal virulence, but that in other cases optimal
virulence is decreased (e.g. for the contact–recovery
trade-off) or unaffected (e.g. for the recovery–mortality
and contact-transmissibility trade-offs) by increasing
treatment rates.
Our analysis reveals the possibility that virulence-
dependent treatment rates (i.e. faster treatment for more
virulent pathogen strains) may counteract evolutionary
pressures toward increased virulence, providing an
additional benefit to such policies (Galvani, 2003). The
model can be extended to explore different modes of
intervention (for instance, partially effective therapy or
infection control measures that reduce transmissibility
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availability of treatment (such as fixed delays rather
than competing exponential risks (Blower et al., 1998)).
A further extension could treat sociological effects of
treatment availability, such as increasing contact rates
or more risky behavior (e.g. Blower and McLean
(1994)).
In the most general setting, including coinfection or
within-host competition between different strains,
strains with the largest reproduction number may not
prevail. Within-host competition may lead to increases
in the virulence of a pathogen beyond what would
optimally maximize the reproduction number (Bremer-
mann and Pickering, 1983; Nowak and May, 1994;
Read and Taylor, 2001; van Baalen and Sabelis, 1995;
van Baalen, 1998; Williams and Nesse, 1991), although
this escalation may be moderate as shown by the
intermediate virulence reached by rabbit myxoma
(Fenner and Myers, 1978; Fenner and Ratcliffe, 1965;
Fenner, 1983). Our model could be extended to include
a fitness function which incorporates within-host com-
petition (Regoes et al., 2000), though in this case host
demography may also need to be considered (Castillo-
Chavez and Velasco-Hernandez, 1998). Other limita-
tions of R0 maximization have been raised (Dieckmann,
2002), including that virulence levels may be coinciden-
tal (e.g. Levin, 1996), but it is still a productive approach
to the study of optimal virulence (e.g. Gandon et al.,
2001; Boots et al., 2004). Within this adaptive frame-
work, we seek to determine the strategy that is
evolutionarily optimal to the pathogen under specified
model assumptions, but are limited in our predictions of
whether such an optimum will actually be reached.
We have defined virulence as the extent of host
exploitation by the pathogen, and used it as a driving
variable for four epidemiological parameters. This
framework is appropriate for pathogens with greatly
differing natural histories, including non-lethal diseases
(e.g. gonorrhea) that are excluded by narrower defini-
tions of virulence that pertain only to disease-induced
death. Furthermore the validity of a simple trade-off
between mortality and transmissibility has been chal-
lenged (Ebert and Bull, 2003a,b). We have reviewed the
empirical evidence for more general trade-offs between
epidemiological parameters (see also Day, 2003), and
presented analysis of this general case. Our study is also
the first, to our knowledge, to explicitly consider the link
between virulence and host contact rates. The functional
dependence of epidemiological parameters on virulence,
however, is difficult to ascertain empirically. A recent
study found dramatic differences in virulence evolution
among models with markedly different formulations of
transmission and host death, suggesting that detailed
quantitative understanding of particular host–parasite
interactions is required to reliably predict virulence
evolution (Ganusov and Antia, 2003). In this paper, wefirst presented general results applicable to arbitrary
functional formulations, then explored examples based
on plausible functional forms and special cases repre-
senting broad classes of disease natural histories.
The models presented in this paper show that
treatment programs may either increase or decrease
the optimal virulence of a pathogen, depending on
details of the host–pathogen interaction. In conjunction
with recent work on vaccination (Gandon et al., 2001,
2003) and drug resistance (Bonhoeffer, 2002), this study
is a step toward understanding the evolutionary
consequences of public health interventions. Further
research, particularly empirical and interdisciplinary
work, may enable evolutionary theory of pathogens to
constructively inform public health decision-making.Acknowledgements
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A.1. Transmission model
Denoting the number of susceptible individuals by X,
the number of infected individuals by Y, and the number
of removed individuals by Z, a simple epidemic model is
as follows:
_X ¼ L mX  bcxpxyX ;
_Y ¼ bcxpxyX  ðmþ dþ rþ fÞY ;
_Z ¼ ðrþ fÞY  mZ
where L is the inflow rate of new susceptibles, m is the
per-capita background removal rate, b is the probability
of pathogen transmission given a contact between a
susceptible and an infective, cx is the contact rate per
susceptible or recovered individual, cy is the contact rate
per infected individual, d is the per-capita disease-
induced mortality rate, r is the per-capita recovery rate
from disease, f is the per-capita treatment rate, and pxy
is the probability that a susceptible will choose an
infective partner:
pxy ¼
cyY
cxX þ cyY þ cxZ
:
Using standard arguments (Anderson and May, 1991;
Bailey, 1975; Kermack and McKendrick, 1927), the
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bcy
rþmþdþf; which is the product of the effective contact
rate E ¼ bcy and the duration of infectivity D ¼ 1=ðrþ
mþ dþ fÞ: The parameters cy; b; d; or r may be affected
by the pathogen virulence v, and f is affected by the
level of treatment effort u (and possibly v as well); we
define the reproduction number in the presence of
treatment effort u as Ru ¼ bcyrþmþdþfðuÞ ¼ EðvÞDðu; vÞ:
Since it arises from a linearization of the differential
equations shown above, this definition of Ru implicitly
assumes an infinite (and hence non-depleting) pool of
susceptibles available to be infected by the index case.
Recent work has shown that using a finite contact
neighborhood places an upper bound on the reproduc-
tion number, and that the standard formulation of R0 is
an overestimate compared to the value obtained when
the susceptible pool is minimal (Keeling and Grenfell,
2000; Aparicio et al., 2000). This effect is strictly
quantitative (i.e. it determines how much R0 changes
as parameters are varied, but not the direction of those
changes), so qualitative conclusions of our study are
unlikely to be affected. The impact on quantitative
predictions of our analysis (e.g. values of v for different
special cases) will be limited in most cases, because
values of Ru are constrained to a limited range by trade-
offs between parameters. An exception is the case TR in
Table 1, for which limiting effects such as finite contact
neighborhood will prevent the optimal virulence from
approaching infinity.
In a system of multiple strains, competition dynamics
determine which strain will dominate (and hence the
level of optimal virulence). Using the established
technique for epidemic models without coinfection
(Bremermann and Thieme, 1989; Saunders, 1981; May
and Anderson, 1983), we have verified for this model
that the pathogen strain with the largest reproduction
number Ru is able to invade and competitively exclude
all other strains (Gupta and Galvani, 1999). Further-
more, there is no coexistence equilibrium for this model
except in the special case where two strains have exactly
equal reproduction numbers.
Proof of Proposition. Let d
du
v40: Then, by Eq. (8),
@E
@v ðvðuÞÞ40; and then by Eq. (3), @D@v ðu; vðuÞÞo0: Since
EðvÞ is unimodal and nonnegative, @E@v has one zero at vt;
and vovt if and only if @E@v40: Thus, since EvðvðuÞÞ40;
vðuÞovt: A similar argument shows that vdov: Thus,
vdovðuÞovt; and so vdovt:Similarly, if dduvðuÞo0;
vtovd ; and if dduvðuÞ ¼ 0; vd ¼ vt:References
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